With the help of nuclear magnetic resonance (NMR) spectroscopy, researchers in the NMR Metabolomics research group are quantitatively investigating metabolic processes in vitro (in functional models under physiological conditions).
The Preclinical Metabolomics research group uses technologies developed at ISAS to investigate metabolic heterogeneity in tumors and their metastases.
The scientists in the research group Proteomics are developing analytical methods with which biomolecules – predominantly proteins – can be assessed qualitatively and quantitatively.
Over five years, the junior research group is going to develop a multi-method approach that will allow the parallel analysis of metabolic processes under spatial and temporal aspects.
Researchers in the Standardisation research group are working towards standardising and accrediting the analytical procedures developed at the Institute, such as those for analysing the thrombocyte proteome, and bringing them to market maturity.